C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia

Inflammation Research

Volumn 61, Issue 1, 2012, Pages 27-35

  Haidet, Jaime ^a,b   Cifarelli, Vincenza ^a   Trucco, Massimo ^a   Luppi, Patrizia ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b AKRON CHILDREN'S HOSPITAL   (United States)

Author keywords

C peptide; Cytokines; Diabetes; Inflammation; Monocytes; NF B

Indexed keywords

C PEPTIDE; CYTOKINE; GLUCOSE; I KAPPA B ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NUCLEAR FACTOR KAPPA B P50 SUBUNIT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; CELL ADHESION; CELL NUCLEUS; CELL STIMULATION; CELL STRAIN U937; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOBLOTTING; IN VITRO STUDY; INCUBATION TIME; INFLAMMATION; INTRACELLULAR SIGNALING; LEUKOCYTE ACTIVATION; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; SUPERNATANT; WESTERN BLOTTING;

AORTA; C-PEPTIDE; CHEMOKINE CCL3; CHEMOKINE CCL4; ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MONOCYTES; PHOSPHORYLATION; U937 CELLS;

EID: 84857631025     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0384-8     Document Type: Article

References (43)

1. Libby P, Nathan DM, Abraham K, et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases working group on cardiovascular complications of type 1 diabetes mellitus. Circulation. 2005;111(25):3489-93. (Pubitemid 40923404)
2. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23):1676-85. (Pubitemid 23157351)
3. Devaraj S, Dasu MR, Jialal I. Diabetes is a proinflammatory state: a translational perspective. Expert Rev Endocrinol Metab. 2010;5(1):19-28.
4. Devaraj S, Glaser N, Griffen S, et al. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006;55(3):774-9. (Pubitemid 43343235)
5. Plesner A, Greenbaum CJ, Gaur LK, et al. Macrophages from high-risk HLA-DQB1*0201/*0302 type 1 diabetes mellitus patients are hypersensitive to lipopolysaccharide stimulation. Scand J Immunol. 2002;56(5):522-9. (Pubitemid 35373690)
6. Erbagci AB, Tarakcioglu M, Coskun Y, et al. Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin Biochem. 2001;34(8):645-50. (Pubitemid 34159356)
7. Rosa JS, Flores RL, Oliver SR, et al. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr Diabetes. 2008;9(1):9-16.
8. Cifarelli V, Libman IM, Deluca A, et al. Increased expression of monocyte CD11b (Mac-1) in overweight recent-onset type 1 diabetic children. Rev Diabet Stud. 2007;4(2):112-7.
9. Devaraj S, Cheung AT, Jialal I, et al. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes. 2007;56(11):2790-6. (Pubitemid 350044923)
10. Saraheimo M, Teppo AM, Forsblom C, et al. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia. 2003;46(10):1402-7. (Pubitemid 37297211)
11. Schalkwijk CG, Ter Wee PM, Stehouwer CD. Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction. Ann NY Acad Sci. 2005;1043:662-70. (Pubitemid 41123957)
12. Zuckerbraun BS, McCloskey CA, Mahidhara RS, et al. Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation. J Vasc Surg. 2003;38(4):812-9. (Pubitemid 37254813)
13. Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element ''decoy'' against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med. 1997;3(8):894-9.
14. Vish MG, Mangeshkar P, Piraino G, et al. Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice. Crit Care Med. 2007;35(5):1348-55. (Pubitemid 46642665)
15. Scalia R, Coyle KM, Levine BJ, et al. C-peptide inhibits leukocyte- endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J. 2000;14(14):2357-64.
16. Young LH, Ikeda Y, Scalia R, et al. C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2000;279(4):H1453-9.
17. Luppi P, Cifarelli V, Tse H, et al. Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway. Diabetologia. 2008;51(8):1534-43.
18. Ekberg K, Brismar T, Johansson BL, et al. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care. 2007;30(1):71-6. (Pubitemid 46061294)
19. Johansson BL, Borg K, Fernqvist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med. 2000; 17(3):181-9. (Pubitemid 30212289)
20. Sima AA, Li ZG. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes. 2005;54(5):1497-505. (Pubitemid 40586682)
21. Panero F, Novelli G, Zucco C, et al. Fasting plasma C-peptide and micro- and macrovascular complications in a large clinicbased cohort of type 1 diabetic patients. Diabetes Care. 2009; 32(2):301-5.
22. Thompson DM, Begg IS, Harris C, et al. Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy. Transplantation. 2008;85(10):1400-5.
23. Remuzzi A, Cornolti R, Bianchi R, et al. Regression of diabetic complications by islet transplantation in the rat. Diabetologia. 2009;52(12):2653-61.
24. Gremizzi C, Vergani A, Paloschi V, et al. Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant. 2010;15(1):119-23.
25. Robertson RP. Update on transplanting beta cells for reversing type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3): 655-67.
26. Luppi P, Geng X, Cifarelli V, et al. C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes. Diabetologia. 2009;52(10):2218-28.
27. Piga R, Naito Y, Kokura S, et al. Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis. 2007;193(2):328-34. (Pubitemid 47058120)
28. Tse HM, Milton MJ, Piganelli JD. Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigenpresenting cells: implication for their use in targeting oxidationreduction reactions in innate immunity. Free Radic Biol Med. 2004;36(2):233-47. (Pubitemid 38117241)
29. SchramMT, ChaturvediN, SchalkwijkC, et al. Vascular risk factors andmarkers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care. 2003;26(7):2165-73.
30. Beyan H, Goodier MR, Nawroly NS, et al. Altered monocyte cyclooxygenase response to lipopolysaccharide in type 1 diabetes. Diabetes. 2006;55(12):3439-45. (Pubitemid 44923603)
31. Litherland SA, Xie XT, Hutson AD, et al. Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest. 1999;104(4):515-23. (Pubitemid 29534335)
32. Cifarelli V, Luppi P, Tse HM, et al. Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis. 2008; 201(2):248-57.
33. Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 1988;242(4878):540-6. (Pubitemid 18263193)
34. Brand K, Page S, Walli AK, et al. Role of nuclear factor-kappa B in atherogenesis. Exp Physiol. 1997;82(2):297-304.
35. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys. 2002;397:342-4. (Pubitemid 34852301)
36. Cifarelli V, Geng X, Styche A, Lakomy B, Trucco M, Luppi P. C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells. Diabetologia. 2011. doi:10.1007/s00125-011-2251-0.
37. Dandona P, Chaudhuri A, Ghanim H, et al. Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose. Semin Thorac Cardiovasc Surg. 2006;18(4):293-301. (Pubitemid 46464512)
38. Hyun E, Ramachandran R, Cenac N, et al. Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response. J Immunol. 2010;184(5):2702-9.
39. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003;88(3):1082-8. (Pubitemid 36337759)
40. Li H, Xu L, Dunbar JC, et al. Effects of C-peptide on expression of eNOS and iNOS in human cavernosal smooth muscle cells. Urology. 2004;64(3):622-7. (Pubitemid 39200786)
41. Mughal RS, Scragg JL, Lister P, et al. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein. Diabetologia. 2010;53(8): 1761-71.
42. Li ZG, Zhang W, Sima AA. C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells. Diabetes Metab Res Rev. 2003;19(5):375-85. (Pubitemid 37185378)
43. Al-Rasheed NM, Chana RS, Baines RJ, et al. Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity. J Biol Chem. 2004;279(48):49747-54. (Pubitemid 39577779)